Singular Genomics Systems (OMIC) Stock Price, News & Analysis

Company Overview

Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology for researchers and clinicians to advance science and medicine. The company is involved in the developing of G4, consisting of G4 instrument and associated consumables for various applications, such as max read kits for single cell sequencing, rare variant detection with high-definition sequencing, gene fusion detection with ring-seq, and extended range sequencing; and PX instrument and associated consumables for applications comprising single cell gene expression and proteomics, in situ RNA sequencing, and spatial RNA and proteomics applications for tissue. Singular Genomics Systems, Inc. was incorporated in 2016 and is based in San Diego, California.

Key Stats

• Today's Range: $20.01 to $20.01
• 50-Day Range: $20.01 to $20.01
• 52-Week Range: $5.34 to $23.41
• Volume: N/A
• Average Volume: 43,845 shs
• Market Capitalization: $50.83 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $6.50
• Consensus Rating: Hold

OMIC Stock Analysis - Frequently Asked Questions

How have OMIC shares performed this year?

Singular Genomics Systems' stock was trading at $19.43 at the beginning of 2025. Since then, OMIC shares have increased by 3.0% and is now trading at $20.01.
View the best growth stocks for 2025 here.

How were Singular Genomics Systems' earnings last quarter?

Singular Genomics Systems, Inc. (NASDAQ:OMIC) released its quarterly earnings results on Tuesday, November, 12th. The company reported ($6.72) earnings per share for the quarter, topping the consensus estimate of ($8.05) by $1.33. The company earned $0.41 million during the quarter, compared to analysts' expectations of $0.74 million. Singular Genomics Systems had a negative net margin of 3,237.89% and a negative trailing twelve-month return on equity of 57.87%.

When did Singular Genomics Systems' stock split?

Singular Genomics Systems's stock reverse split on the morning of Wednesday, June 26th 2024. The 1-30 reverse split was announced on Wednesday, June 26th 2024. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, June 26th 2024. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

When did Singular Genomics Systems IPO?

Singular Genomics Systems (OMIC) raised $178 million in an initial public offering (IPO) on Thursday, May 27th 2021. The company issued 8,500,000 shares at $20.00-$22.00 per share. J.P. Morgan, Goldman Sachs, BofA Securities, Cowen and UBS Investment Bank served as the underwriters for the IPO.

How do I buy shares of Singular Genomics Systems?

Shares of OMIC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Singular Genomics Systems own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Singular Genomics Systems investors own include NVIDIA (NVDA), Tesla (TSLA), Albemarle (ALB), CrowdStrike (CRWD), Etsy (ETSY), Ford Motor (F) and Fluence Energy (FLNC).

Company Calendar

• Last Earnings: 11/12/2024
• Today: 5/22/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Analytical instruments
• Sub-Industry: Measuring And Control Equipment
• Current Symbol: NASDAQ:OMIC
• CIK: 1850906
• Web: singulargenomics.com
• Phone: 858-333-7830
• Fax: N/A
• Employees: 220
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $6.50
• High Stock Price Target: $6.50
• Low Stock Price Target: $6.50
• Potential Upside/Downside: -67.5%
• Consensus Rating: Hold
• Rating Score (0-4): 2.00
• Research Coverage: 1 Analysts

Profitability

• EPS (Most Recent Fiscal Year): ($35.1096)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-94,820,000.00
• Net Margins: -3,237.89%
• Pretax Margin: -3,237.89%
• Return on Equity: -57.87%
• Return on Assets: -37.90%

Debt

• Debt-to-Equity Ratio: 0.04
• Current Ratio: 7.37
• Quick Ratio: 6.67

Sales & Book Value

• Annual Sales: $2.91 million
• Price / Sales: 17.47
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $73.25 per share
• Price / Book: 0.27

Miscellaneous

• Outstanding Shares: 2,540,000
• Free Float: 1,974,000
• Market Cap: $50.83 million
• Optionable: No Data
• Beta: 1.83